| Literature DB >> 32571532 |
Yu-Lin Cao1, Yan-Jiu Han1, Peng Chen1, Ze-Ming Liu2, Muradil Mutar3, Yong Gao1, Zeng-Wu Shao1, Wei Tong1, Yong Liu4.
Abstract
Since December 2019, COVID-19, an acute infectious disease, has gradually become a global threat. We report a case of thoracolumbar fractures (T12 and L1) and incomplete lower limb paralysis in a patient with COVID-19. After a series of conservative treatment which did not work at all, posterior open reduction and pedicle screw internal fixation of the thoracolumbar fracture were performed in Wuhan Union Hospital. Three weeks later, the patient could stand up and the pneumonia is almost cured. We successfully performed a surgery in a COVID-19 patient, and to our knowledge it is the first operation for a COVID-19 patient ever reported.Entities:
Keywords: COVID-19; Cytokine storm; Surgery; Vertebrate fracture
Mesh:
Year: 2020 PMID: 32571532 PMCID: PMC7241380 DOI: 10.1016/j.cjtee.2020.05.005
Source DB: PubMed Journal: Chin J Traumatol ISSN: 1008-1275
Fig. 1On 19 February, (A) the thoracolumbar computed tomography (CT) showed thoracic 12 vertebra burst fractures, lumbar 1 vertebral compression fractures; (B) the lung CT showed bilateral pulmonary exudative changes.
Laboratory examinations since admission.
| Items | Reference range | Days after hospitalization | |||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 6∗ | 7 | 13 | 21 | ||
| White-cell count (g/L) | 3.5–9.5 | 11.89↑ | 8.55 | 16.54↑ | 16.55↑ | 9.89 | 8.26 |
| Red-cell count (g/L) | 3.8–5.1 | 5.23↑ | 5.39↑ | 4.73 | 4.17 | 4.07 | 4.49 |
| Absolute neutrophil count (g/L) | 1.8–6.3 | 9.35↑ | 6.37 | 14.03↑ | 14.61↑ | 7.16↑ | 5.56 |
| Absolute lymphocyte count (g/L) | 1.1–3.2 | 1.69 | 1.57 | 1.06↓ | 1.05↓ | 2.02 | 2.03 |
| Platelet count (g/L) | 125–350 | 232 | 193 | 242 | 203 | 329 | 336 |
| Hemoglobin (g/L) | 130–175 | 163 | 165 | 149 | 130 | 125↓ | 139 |
| Hematocrit (%) | 40–50 | 48.0 | 49.0 | 43.8 | 38.7 | 38.1 | 42.2 |
| Sodium (mmol/L) | 137–147 | 137.6 | 137.5 | 140.8 | 137.7 | 137.9 | 138.9 |
| Potassium (mmol/L) | 3.5–5.3 | 4.16 | 3.68 | 4.32 | 5.43↑ | 4.80 | 4.15 |
| Chloride (mmol/L) | 96–108 | 107.6 | 104.0 | 105.0 | 102.2 | 97.6 | 98.8 |
| Calcium (mg/L) | 2.0–2.5 | 2.05 | 2.09 | 1.97↓ | 2.10↓ | 2.28 | 2.25 |
| Carbon dioxide (mmol/L) | 20–29 | 25.4 | 29.6 | 25.9 | 25.1 | 34.2↑ | 28.1 |
| Anion gap (mmol/L) | 8–16 | 5↓ | 4↓ | 10 | 10 | 6↓ | 12 |
| Glucose (mmol/L) | 3.9–6.1 | 5.96 | 6.66 | 6.89 | 7.44 | 5.77 | 5.86 |
| Blood urea nitrogen (mg/L) | 2.9–8.2 | 9.18↑ | 9.21↑ | 6.65 | 5.7 | 4.54 | 4.59 |
| Creatinine (mg/L) | 57–111 | 71.8 | 73.1 | 63.1 | 67 | 59.1 | 67.3 |
| Total protein (g/L) | 60–83 | 68.0 | 71.6 | 58.1↓ | 57.3 | 63.3 | 66.9 |
| Albumin (g/L) | 33–55 | 38.6 | 42.3 | 33.3 | 31.0↓ | 33.4 | 40.6 |
| total bilirubin (umol/L) | 3–20 | 15.8 | 15.7 | 18.8 | 13.6 | 8.0 | 8.6 |
| Procalcionin (ng/ml) | <0.05 | 0.04 | 0.05↑ | – | 0.25↑ | – | – |
| Alanine aminotransferase (U/L) | 5–40 | 24 | 62↑ | 48↑ | 32 | 84↑ | 54↑ |
| Aspartate aminotransferase (U/L) | 8–40 | 17 | 34 | 36 | 26 | 39 | 26 |
| Alkaline phosphatase (U/L) | 40–150 | 130 | 143 | 172↑ | 156↑ | 290↑ | 313↑ |
| D-dimer (ug/ml) | 0–0.5 | 1.26↑ | 1.70↑ | 2.56↑ | 2.00↑ | 3.27↑ | 1.84↑ |
| Fibrinogen (g/l) | 2–4 | 3.37 | 3.59 | 5.52↑ | 7.44↑ | 6.34↑ | 4.73↑ |
| Lacate dehydrogenase (U/L) | 109–245 | 186 | 201 | 265↑ | 223 | 200 | 157 |
| Prothrombin time (sec) | 11.0–16.0 | 13.1 | 12.7 | 13.1 | 14.3 | 13.4 | 13.0 |
| International normal ratio | 0.83–1.36 | 1.01 | 0.97 | 1.01 | 1.14 | 1.04 | 1.00 |
| Creatine kinase (U/L) | 24–194 | 227↑ | 170 | – | 807↑ | 85 | 54 |
| CRP (mg/L) | 0–8 | 0.47 | 0.10 | 65.84↑ | 170.28↑ | 3.12 | 1.06 |
−: not detected, ↑: higher than normal upper limit, ↓: lower than normal lower limit, ∗: the patient received surgery on this day.
CRP: C-reactive protein.
Fig. 2Changes in muscle strength.
Lymphocyte subsets, plasma cytokines, 2019-nCoV antibodies 2019-nCoV nucleic acid.
| Items | Feb.17 | Feb.25 | Feb.28 | Mar.1 | Mar.4 | Mar.7 | Mar.9 | Mar.10 |
|---|---|---|---|---|---|---|---|---|
| IL-2 (0.1–4.1pg/mL) | 26.22↑ | 9.18↑ | ||||||
| IL-4 (0.1–3.2 pg/mL) | 4.97↑ | 4.96↑ | ||||||
| IL-6 (0.1–2.9 pg/mL) | 4.72 | 8.55↑ | 6.38 | 9.93↑ | ||||
| IL-10 (0.1–5.0 pg/mL) | 4.2 | 7.45↑ | ||||||
| TNF-α (0.1–23 pg/mL) | 3.68 | 5.41 | ||||||
| IFN-γ (0.1–18 pg/mL) | 8.55 | 4.56 | ||||||
| CD3+ Lymphocyte (58.17%–84.22%) | 76.14 | 72.38 | ||||||
| CD4+ Lymphocyte (25.34%–51.37%) | 41.4 | 39.91 | ||||||
| CD8+ Lymphocyte (14.23%–38.95%) | 30.12 | 30.26 | ||||||
| B Lymphocyte (4.1%–18.31%) | 18.97 | 20.6 | ||||||
| NK Lymphocyte (3.33%–30.47%) | 1.81 | 5.18 | ||||||
| CD4/CD8 (0.41–2.72) | 1.36 | 1.32 | ||||||
| 2019-nCov-IgM (<10) | 0.26 | |||||||
| 2019-nCov-IgG (<10) | 0.47 | |||||||
| Nucleic acid of SARS-CoV-2 | + | – | – | – |
+: positive, −: negative, ↑: higher than normal upper limit, ↓: lower than normal lower limit.
Fig. 3(A) Re-examination of thoracolumbar and lung computed tomography revealed that the spinal reduction was satisfactory, and (B) the lung infection was absorbed earlier.